Patrick Vermersch

23.4k total citations · 6 hit papers
391 papers, 13.7k citations indexed

About

Patrick Vermersch is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Patrick Vermersch has authored 391 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 227 papers in Pathology and Forensic Medicine, 116 papers in Neurology and 73 papers in Oncology. Recurrent topics in Patrick Vermersch's work include Multiple Sclerosis Research Studies (208 papers), Peripheral Neuropathies and Disorders (80 papers) and Polyomavirus and related diseases (59 papers). Patrick Vermersch is often cited by papers focused on Multiple Sclerosis Research Studies (208 papers), Peripheral Neuropathies and Disorders (80 papers) and Polyomavirus and related diseases (59 papers). Patrick Vermersch collaborates with scholars based in France, United States and Germany. Patrick Vermersch's co-authors include J. de Sèze, Didier Leys, Tanya Stojkovic, M Steinling, Jean‐Pierre Pruvo, Frederik Barkhof, Philip Scheltens, Jaap Valk, Hélène Zéphir and Gavin Giovannoni and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Patrick Vermersch

375 papers receiving 13.3k citations

Hit Papers

Atrophy of medial temporal lobes on MRI in "probable" Alz... 1992 2026 2003 2014 1992 1993 2010 1999 2008 400 800 1.2k

Peers

Patrick Vermersch
Comparison fields: 5 of 153
  • Pathology and Forensic Medicine 6.8k
  • Neurology 4.6k
  • Physiology 2.6k
  • Rheumatology 2.3k
  • Psychiatry and Mental health 2.1k
Replace Joseph E. Parisi with:
Joseph E. Parisi United States
Jens Kühle Switzerland
Robert Zivadinov United States
Friedemann Paul Germany
Carlo Pozzilli Italy
Fredrik Piehl Sweden
Bernard M.J. Uitdehaag Netherlands
Bianca Weinstock‐Guttman United States
Gianluigi Mancardi Italy
Rohit Bakshi United States
Joseph E. Parisi United States View profile →
Citations per field, relative to Patrick Vermersch
Patrick Vermersch · 1×
Citations per year, relative to Patrick Vermersch
Patrick Vermersch · 1×

Countries citing papers authored by Patrick Vermersch

Since Specialization
Citations

This map shows the geographic impact of Patrick Vermersch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Vermersch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Vermersch more than expected).

Fields of papers citing papers by Patrick Vermersch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Vermersch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Vermersch. The network helps show where Patrick Vermersch may publish in the future.

Co-authorship network of co-authors of Patrick Vermersch

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Vermersch. A scholar is included among the top collaborators of Patrick Vermersch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Vermersch. Patrick Vermersch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 2
3 32
4 34
5 1
6 0
7 3
8 2
9 11
10 36
11 11
12 7
13 95
14
Tolerability profile of cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis: factors contributing to treatment completion overall and in patients with high disease activity in the 96-week CLARITY study
1
15 42
16
Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study
9
17
Immunologie de la sclérose en plaques : évolution des concepts
1
18
Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
25
19
Actualités thérapeutiques dans la sclérose en plaques
1
20
L'observation systématique dans l'étude du fonctionnement cognitif
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026